Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India

Background: Paget’s disease of bone (PDB) is associated with considerable morbidity because of bony pains, fractures, and deformities. Remission, as assessed by reduction in alkaline phosphatase levels, does not necessarily correlate with improvement in quality of life (QoL). Health-related quality...

Full description

Saved in:
Bibliographic Details
Main Authors: Fibi K. Ninan, Kripa Elizabeth Cherian, Remya Rajan, Felix Jebasingh, Nitin Kapoor, Hesarghatta S. Asha, Nihal Thomas, Thomas V. Paul
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_1155_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858098822971392
author Fibi K. Ninan
Kripa Elizabeth Cherian
Remya Rajan
Felix Jebasingh
Nitin Kapoor
Hesarghatta S. Asha
Nihal Thomas
Thomas V. Paul
author_facet Fibi K. Ninan
Kripa Elizabeth Cherian
Remya Rajan
Felix Jebasingh
Nitin Kapoor
Hesarghatta S. Asha
Nihal Thomas
Thomas V. Paul
author_sort Fibi K. Ninan
collection DOAJ
description Background: Paget’s disease of bone (PDB) is associated with considerable morbidity because of bony pains, fractures, and deformities. Remission, as assessed by reduction in alkaline phosphatase levels, does not necessarily correlate with improvement in quality of life (QoL). Health-related quality of life (HR-QoL) in affected individuals is not well-studied in India. This study attempts to describe the QoL in individuals with PDB. Methods: In this prospective observational study spanning 6 years (Jan 2017–Dec 2022), we included 29 treatment-naïve patients diagnosed with PDB based on clinical, biochemical, and radiographic features. All patients received treatment with antiresorptive agents. SF-36 questionnaire was administered before treatment and at review. Results: A total of 29 patients with PDB (20 males), with a mean (SD) age of 68.1 (9.8) years, were included. Symptomatic disease was seen in 23/29 (79.3%) and polyostotic disease in 25/29 (86%) subjects. The median duration of symptoms was 6 months (0–24 months). The most frequently involved skeletal sites were the pelvis (69%), vertebrae and sacrum (68%), followed by the skull (48%) and lower limb (48%). The subjects were treated with parenteral zoledronate (65.5%), oral alendronate (24.1%), and denosumab (6.9%). There was a significant improvement in all eight domains of QoL (P = 0.0001) as assessed by the SF-36 questionnaire. The maximum improvement (27.2%) was observed in the physical functioning domain (P = 0.0001). Conclusion: This study assessed various domains in QoL by using the SF-36 questionnaire at baseline and post-treatment with antiresorptive agents, and it was noted that there was a significant improvement in all domains of QoL.
format Article
id doaj-art-10d043e55f774b87b3bfb0fe5a7b4af5
institution Kabale University
issn 2249-4863
2278-7135
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj-art-10d043e55f774b87b3bfb0fe5a7b4af52025-02-11T13:56:06ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352025-01-0114137137610.4103/jfmpc.jfmpc_1155_24Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern IndiaFibi K. NinanKripa Elizabeth CherianRemya RajanFelix JebasinghNitin KapoorHesarghatta S. AshaNihal ThomasThomas V. PaulBackground: Paget’s disease of bone (PDB) is associated with considerable morbidity because of bony pains, fractures, and deformities. Remission, as assessed by reduction in alkaline phosphatase levels, does not necessarily correlate with improvement in quality of life (QoL). Health-related quality of life (HR-QoL) in affected individuals is not well-studied in India. This study attempts to describe the QoL in individuals with PDB. Methods: In this prospective observational study spanning 6 years (Jan 2017–Dec 2022), we included 29 treatment-naïve patients diagnosed with PDB based on clinical, biochemical, and radiographic features. All patients received treatment with antiresorptive agents. SF-36 questionnaire was administered before treatment and at review. Results: A total of 29 patients with PDB (20 males), with a mean (SD) age of 68.1 (9.8) years, were included. Symptomatic disease was seen in 23/29 (79.3%) and polyostotic disease in 25/29 (86%) subjects. The median duration of symptoms was 6 months (0–24 months). The most frequently involved skeletal sites were the pelvis (69%), vertebrae and sacrum (68%), followed by the skull (48%) and lower limb (48%). The subjects were treated with parenteral zoledronate (65.5%), oral alendronate (24.1%), and denosumab (6.9%). There was a significant improvement in all eight domains of QoL (P = 0.0001) as assessed by the SF-36 questionnaire. The maximum improvement (27.2%) was observed in the physical functioning domain (P = 0.0001). Conclusion: This study assessed various domains in QoL by using the SF-36 questionnaire at baseline and post-treatment with antiresorptive agents, and it was noted that there was a significant improvement in all domains of QoL.https://journals.lww.com/10.4103/jfmpc.jfmpc_1155_24bisphosphonatesindiapaget’s disease of bonequality of life
spellingShingle Fibi K. Ninan
Kripa Elizabeth Cherian
Remya Rajan
Felix Jebasingh
Nitin Kapoor
Hesarghatta S. Asha
Nihal Thomas
Thomas V. Paul
Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
Journal of Family Medicine and Primary Care
bisphosphonates
india
paget’s disease of bone
quality of life
title Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
title_full Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
title_fullStr Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
title_full_unstemmed Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
title_short Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
title_sort health related quality of life following bisphosphonate therapy in individuals with paget s disease of bone a study from a teaching hospital in southern india
topic bisphosphonates
india
paget’s disease of bone
quality of life
url https://journals.lww.com/10.4103/jfmpc.jfmpc_1155_24
work_keys_str_mv AT fibikninan healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT kripaelizabethcherian healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT remyarajan healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT felixjebasingh healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT nitinkapoor healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT hesarghattasasha healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT nihalthomas healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia
AT thomasvpaul healthrelatedqualityoflifefollowingbisphosphonatetherapyinindividualswithpagetsdiseaseofboneastudyfromateachinghospitalinsouthernindia